MMF Ismail, MS Ayoup - RSC advances, 2022 - pubs.rsc.org
FDA-approved antiviral agents represent an important class that has attracted attention in recent years to combat current and future threats of viral pandemics. Fluorine ameliorates …
Acquired immunodeficiency syndrome (AIDS) is a chronic and potentially fatal ailment caused by the human immunodeficiency virus (HIV) and remains a major health problem …
CH Park, YL Oh, JH Shin, YJ Park - Molecules, 2024 - mdpi.com
Ganoderma lucidum, a member of the Basidiomycetes family, is attracting attention for its medicinal potential due to its biological activity and the presence of numerous bioactive …
The emergence of drug-resistant Human Immunodeficiency Virus-1 strains against anti-HIV therapies in the clinical pipeline, and the persistence of HIV in cellular reservoirs remains a …
P Jadaun, R Harshithkumar, C Seniya… - Frontiers in …, 2024 - frontiersin.org
Asparagus racemosus (AR), an Ayurvedic botanical, possesses various biological characteristics, yet its impact on HIV-1 replication remains to be elucidated. This study aimed …
In our continued study on the anti-HIV activity of compounds present in CareVidTM, we report the HIV-1 integrase ((HIV-1 IN) inhibitory effects of pellitorine (1), oleuropein (2) …
RK Upadhyay - International Journal of Green Pharmacy (IJGP), 2023 - greenpharmacy.info
Present article explains human immunodeficiency virus (anti-HIV) activity of various bioorganic components isolated from various plant species. Plants possess enormous …
F Karadeniz, SK Kim - Current Issues in Molecular Biology, 2024 - mdpi.com
Despite present antiviral agents that can effectively work against HIV-1 replication, side effects and drug resistance have pushed researchers toward novel approaches. In this …
MS Serna-Arbeláez, V García-Cárcamo… - Current Issues in …, 2023 - mdpi.com
HIV-1 infection is considered one of the major public health problems worldwide. Due to the limited access to antiretroviral therapy, the associated side effects, and the resistance that …